The 4th World Parkinson Congress takes September 20-23, 2016 in Portland, Oregon.
All articles by Tori Rodriguez, MA, LPC
Previous studies have investigated the effects of exposing aged mice to the blood of young mice through heterochronic parabiosis or via injection of young blood plasma.
Combined treatment approaches are more beneficial than single approaches for chronic pain conditions like migraine.
VEEG abnormalities were detected in 56.7% of patients, and these were a statistically significant predictor of recurring seizure.
Patients taking levetiracetam should be monitored for AIPD.
Dementia risk was elevated in those who had higher scores on cognitive tests at baseline.
Clinicians need to remain vigilant when prescribing tramadol, as its concurrent use with opioids poses a risk of serotonin toxicity.
The new guidelines include a step-by-step diagnostic algorithm for use in the clinical setting, as well as a special emphasis on neurobehavioral impairment.
Neurologists should collaborate with other specialties in order to increase awareness of migraine prevalence in men.
New findings suggest shared genetic etiology vs causal relationship in comorbid migraine and depression.
It has been proposed that the gut microbiome may be an important environmental risk factor in MS.
Myoclonic seizures may be easily mistaken for a possible tic disorder if the proper patient monitoring is not conducted during diagnosis.
It’s important for pediatric neurologists to spend time preparing the patient for the transition to adult care.
According to a 2010 report based on a survey of caregivers of people with DLB, 78% of cases were initially misdiagnosed.
Findings suggest that interactions between beta-amyloid and tau lead to neurodegeneration in Alzheimer’s.
The mSTESS predicted mortality at a rate of 80.1%.
Pain relief was linked to significant improvements in sleep, among other factors.
Medication, plus a relatively sedentary lifestyle, places people with epilepsy at great risk of metabolic syndrome and its various complications.
This is the first study to examine the role of CSF biomarkers in the diagnosis of patients with cognitive symptoms and psychiatric disorders in routine daily clinical practice.
The guidelines are the result of a consensus of an international task force of MG experts.
The registry is a centralized data collection system that analyzes data on quality of care and patient outcomes.
More than 50% of patients with migraine are treated with opioids in the ED despite known risks.
Some patients who are approaching seizure control can achieve improvement or seizure freedom by addressing sleep issues.
With a lack of official treatment guidelines, clinicians should remember to treat the patient, not just the condition.
The authors are primarily concerned with the overlap of therapies being used in these patients.
Researchers at several U.S. universities conducted a review and meta-analysis of studies investigating the use of computerized provider order entry in hospital-based settings.
Those treated with phenytoin saw a 30% reduction in retinal nerve fiber loss.
When first-line therapies fail, physicians must consider several factors when choosing the next course of treatment for their RRMS patients.